| 1 |
Igor Legen |
Lek Pharmaceuticals D. D. |
8 |
| 2 |
Tadej Knez |
Raycap Ip Development |
7 |
| 2 |
Janez Bester |
— |
7 |
| #4 |
Anton {hacek over (S)}ifrar |
— |
5 |
| #5 |
Barbara Mohar |
Lek Pharmaceuticals D. D. |
4 |
| #5 |
Gregor Dolsak |
Renishaw Plc |
4 |
| #7 |
Maja Remskar |
Institut Jozef Stefan |
3 |
| #7 |
Klemen Kastelic |
— |
3 |
| #7 |
Anton Sifrar |
— |
3 |
| #7 |
Mirjan Zorz |
— |
3 |
| #7 |
Marko Virsek |
Institut Jozef Stefan |
3 |
| #7 |
Tomaz Javornik |
— |
3 |
| #7 |
Ziga Ahec |
Mahle International Gmbh |
3 |
| #14 |
Tine Tav{hacek over (c)}ar |
Ripd Research And Ip Development |
2 |
| #14 |
Jure Bambic |
— |
2 |
| #14 |
Jaka Caric |
— |
2 |
| #14 |
Mladen Brajkovic |
— |
2 |
| #18 |
Jure Stari{hacek over (c)} |
— |
1 |
| #18 |
Franc {haeck over (C)}ernec |
— |
1 |
| #18 |
Helena Seme |
— |
1 |
| #18 |
Mitja Mahnic |
— |
1 |
| #18 |
Marjana Fortuna |
Lek Pharmaceuticals D. D. |
1 |
| #18 |
Mitja Mahni{hacek over (c)} |
— |
1 |
| #18 |
Marko Virsek |
— |
1 |
| #18 |
Alojz Cimerman |
— |
1 |
| #18 |
Srdjan Novakovic |
Lek, Tovarna Farmacevtskih In Kemicnih Izdelkov, D.D. |
1 |
| #18 |
Jaroslav Simunek |
— |
1 |
| #18 |
Jan Smidrkal |
— |
1 |
| #18 |
Vaclav Krob |
— |
1 |
| #18 |
Jan Novak |
— |
1 |
| #18 |
Slavko Medimurec |
— |
1 |